Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • BFSI
      • Capital Goods
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Auto
    • Real Estate
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»National»Prime Minister’s Vision for a Self-Reliant India Finds Momentum in Scanbo’s Made-in-India MedTech Innovation
    National

    Prime Minister’s Vision for a Self-Reliant India Finds Momentum in Scanbo’s Made-in-India MedTech Innovation

    Pawan sharmaBy Pawan sharmaNovember 21, 2025No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Surat (Gujarat) [India], November 21: India’s healthcare landscape is rapidly evolving, and the idea of a self-reliant nation now extends beyond heavy industries to include medical technology. One company reflecting this shift is Scanbo, a home-grown MedTech innovator developing next-generation diagnostic devices entirely in India. As the country embraces Prime Minister Narendra Modi’s “Make in India” movement, Scanbo stands out as a strong example of how indigenous technology can transform healthcare access at scale.

    The Need for Home-Grown Diagnostic Innovation

    For millions in rural and semi-urban areas, basic diagnostic testing often means long travel, delays, and limited accessibility. This gap highlighted the need for compact, affordable, and accurate point-of-care tools. Scanbo was built from this challenge, aiming to bring hospital-grade diagnostics closer to people. By combining artificial intelligence and sensor fusion, the company created a compact device that delivers lab-quality results within minutes at the point of care.

    D8: Laying the Foundation

    Scanbo’s first major device, the D8, performs seven non-invasive tests—blood pressure, heart rate, heart rate variability, breathing rate, oxygen saturation, temperature, and a single-lead ECG—along with a simple finger-prick blood glucose test. Designed and manufactured in India, it blends precise hardware with intelligent software that analyzes results in real time. For doctors, it reduces dependence on bulky equipment; for patients, it brings reliable diagnostics into homes, clinics, and workplaces.

    AI and HridaayTaal

    At the core of Scanbo’s technology is its proprietary AI engine, HridaayTaal, which interprets cardiac signals and identifies irregularities such as arrhythmia and atrial fibrillation. The company is expanding this platform to assess advanced cardiac intervals, detect sleep apnea, and recognize complex rhythm patterns. Each update moves the system closer to preventive, AI-driven cardiovascular monitoring.

    From D8 to D19

    While the D8 set the foundation, Scanbo’s roadmap includes the D12, D16, and D19—devices planned from 2026 to 2028 that will add multiple blood tests and broaden first-level diagnostics. This phased approach reflects a strategy to make healthcare faster and more self-sufficient by reducing dependence on external laboratories.

    Blockchain and Digital Integration

    Beyond devices, Scanbo is creating a blockchain-based healthcare data ecosystem to ensure secure, transparent, and patient-controlled data exchange. This digital layer solves long-standing issues of trust and interoperability while supporting real-time access for patients and providers.

    Affordability and Accessibility

    By integrating multiple tests into one portable device, Scanbo reduces redundancy and lowers per-test costs. These devices can be deployed in small clinics, mobile health units, and remote regions without significant infrastructure, strengthening India’s public health network and enabling earlier detection of chronic conditions.

    Empowering Indian Manufacturing

    Scanbo’s journey highlights India’s growing confidence in its ability to design and produce advanced MedTech domestically. Its reliance on Indian engineers, researchers, and suppliers creates local employment while proving that high-quality MedTech can be built in India for both domestic and global markets.

    “Our mission is simple: build world-class diagnostic technology in India, for India and the world,” said Ashissh Raichura, Founder & CEO of Scanbo. “Prime Minister Modi’s vision of a self-reliant Bharat inspires us to innovate and manufacture on Indian soil.”

    The Road Ahead

    Like all transformative technologies, the journey includes challenges—regulatory approvals, manufacturing scale, and clinical validation. Yet, Scanbo’s consistent progress, strategic partnerships, and user-centric design show a clear path forward.

    Conclusion

    Scanbo’s progress reflects India’s growing leadership in healthcare innovation. Through the D8 and its upcoming devices, along with AI and blockchain integration, the company is redefining diagnostics as fast, reliable, and Made-in-India. By building advanced technology domestically, Scanbo helps translate vision of self-reliance into a practical reality that strengthens India’s healthcare system and sets an example for the world.

    national
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Pawan sharma
    • Website

    Related Posts

    ACTIZEET® Cares Launches Emergency Flood Relief Initiative for Families Affected by the Assam Floods

    August 4, 2026

    Government, Judiciary and Industry Unite to Advance Workplace Safety at the 4th National POSH Conclave

    July 28, 2026

    Beyond Metros: How Tier-2 Cities Are Powering India’s Economic Engine

    July 27, 2026

    Comments are closed.

    Recent Post
    • From Andaman to Bollywood: Meghhaa Kaour Wins Hearts in ‘Piya Be Dardi’
    • How EZ Legal Hire is Transforming Access to Legal Services in the UAE
    • Master Trust Reports Q1 FY27 Performance with 13.8% Growth in Total Income & 27.8% Surge in PAT
    • Curated Quality, Executed at Scale: Rajni Dutta Art & Design Delivers Artist-Led Creative Experiences in Delhi NCR
    • 50,000+ Burgers & Cold Coffees in a Day: Ajay’s Café’s Friendship Day Surge Signals the Strength of Gujarat’s Homegrown Café Leader
    • Agarwal Toughened Glass India Limited Q1 FY27 Business Update, Revenue grows ~23% QoQ to ₹ 34.40 Crores
    • Amir Chand Jagdish Kumar (Exports) Reports Strong Q1 FY27 Performance; PAT Surges 127.6% YoY
    • Remittix Markets Launch Turns RTX Into A Multi-Product Crypto Ecosystem

    Type above and press Enter to search. Press Esc to cancel.